Podcast 41: API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains 

The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages…

Podcast 38: CDMOs/CMOs Expand High-Potency API Manufacturing

Growth in the oncology drug market continues to spur demand for high-potency API manufacturing. Which CDMOs/CMOs are expanding? DCAT Value Chain Insights rounds up the latest investments. Key topics: (see Chapter Markers…

Podcast 37: Incorporating Sustainability into the Bio/Pharma Supply Chain: Where Does the Industry Stand?

A newly released DCAT benchmarking study examines the targets and progress made by bio/pharma companies and suppliers in reaching their sustainability goals. Key topics: (see Chapter Markers in drop down…

Podcast 36: CDMOs/CMOs Ramp Up Biomanufacturing Capacity

Capital investments are ramping up in biomanufacturing, which continues to be an active area for CDMOs/CMOs in both traditional biologics and new modalities. Which companies are expanding? Key topics: (see…

Podcast 35: How Can Today’s Supply-Chain Challenges Be Fixed?

A DCAT Week program brings together leading Bio/Pharma executives to offer their perspectives on how Bio/Pharma companies and their suppliers are adjusting supply practices now and in the near term.…